WO2007003768A3 - Use of an extract of the species trigonella foenum graecum in a cosmetic or pharmaceutical composition - Google Patents

Use of an extract of the species trigonella foenum graecum in a cosmetic or pharmaceutical composition Download PDF

Info

Publication number
WO2007003768A3
WO2007003768A3 PCT/FR2006/001522 FR2006001522W WO2007003768A3 WO 2007003768 A3 WO2007003768 A3 WO 2007003768A3 FR 2006001522 W FR2006001522 W FR 2006001522W WO 2007003768 A3 WO2007003768 A3 WO 2007003768A3
Authority
WO
WIPO (PCT)
Prior art keywords
cosmetic
pharmaceutical composition
species
extract
trigonella foenum
Prior art date
Application number
PCT/FR2006/001522
Other languages
French (fr)
Other versions
WO2007003768A2 (en
Inventor
Farra Claude Dal
Nouha Domloge
Dominique Peyronel
Original Assignee
Soc Extraction Principes Actif
Farra Claude Dal
Nouha Domloge
Dominique Peyronel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soc Extraction Principes Actif, Farra Claude Dal, Nouha Domloge, Dominique Peyronel filed Critical Soc Extraction Principes Actif
Publication of WO2007003768A2 publication Critical patent/WO2007003768A2/en
Publication of WO2007003768A3 publication Critical patent/WO2007003768A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)

Abstract

The invention relates to the use of at least one isoleucine, monohydroxlated or polyhydroxylated amino acid, and/or one of the derivatives thereof, as an active agent for inducing the endogenous synthesis of the SIRT proteins in skin cells, in or for the preparation of a cosmetic or pharmaceutical composition.
PCT/FR2006/001522 2005-07-01 2006-06-29 Use of an extract of the species trigonella foenum graecum in a cosmetic or pharmaceutical composition WO2007003768A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0507043A FR2887773B1 (en) 2005-07-01 2005-07-01 USE OF AN AMINO ACID AS AN ACTIVE AGENT INDUCING THE SYNTHESIS OF SIRT PROTEINS IN SKIN CELLS.
FR0507043 2005-07-01

Publications (2)

Publication Number Publication Date
WO2007003768A2 WO2007003768A2 (en) 2007-01-11
WO2007003768A3 true WO2007003768A3 (en) 2007-03-29

Family

ID=35985351

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2006/001522 WO2007003768A2 (en) 2005-07-01 2006-06-29 Use of an extract of the species trigonella foenum graecum in a cosmetic or pharmaceutical composition

Country Status (2)

Country Link
FR (1) FR2887773B1 (en)
WO (1) WO2007003768A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101973900A (en) * 2010-09-21 2011-02-16 徐州技源天然保健品有限公司 Production process for deodorizing and decolorizing fenugreek seed extract
DE102022001711A1 (en) 2022-05-17 2023-11-23 Mercedes-Benz Group AG System for monitoring the attention of a person driving a vehicle

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0587476A1 (en) * 1992-09-07 1994-03-16 Société Civile JOUVENET Compositions containing mono or polyhydroxylated amino acids for the treatment of non-insulin dependent diabetes mellitus
FR2852841A1 (en) * 2003-03-28 2004-10-01 Vincience COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING AMINO ACIDS, USES AND METHODS OF TREATMENT
FR2856297A1 (en) * 2003-06-18 2004-12-24 Caster Cosmetic composition for topical application, especially for combating age-related hair loss, comprises (2S,3R,4S)-4-hydroxyisoleucine
WO2005002555A2 (en) * 2003-07-01 2005-01-13 President And Fellows Of Harvard College Sirt1 modulators for manipulating cell/organism lifespan/stress response
WO2005039626A2 (en) * 2003-10-27 2005-05-06 Innodia Inc. Use of hydroxylated amino acids for treating diabetes

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0587476A1 (en) * 1992-09-07 1994-03-16 Société Civile JOUVENET Compositions containing mono or polyhydroxylated amino acids for the treatment of non-insulin dependent diabetes mellitus
FR2852841A1 (en) * 2003-03-28 2004-10-01 Vincience COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING AMINO ACIDS, USES AND METHODS OF TREATMENT
FR2856297A1 (en) * 2003-06-18 2004-12-24 Caster Cosmetic composition for topical application, especially for combating age-related hair loss, comprises (2S,3R,4S)-4-hydroxyisoleucine
WO2005002555A2 (en) * 2003-07-01 2005-01-13 President And Fellows Of Harvard College Sirt1 modulators for manipulating cell/organism lifespan/stress response
WO2005039626A2 (en) * 2003-10-27 2005-05-06 Innodia Inc. Use of hydroxylated amino acids for treating diabetes

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PORCU M ET AL: "The emerging therapeutic potential of sirtuin-interacting drugs: from cell death to lifespan extension", TRENDS IN PHARMACOLOGICAL SCIENCES, ELSEVIER, HAYWARTH, GB, vol. 26, no. 2, February 2005 (2005-02-01), pages 94 - 103, XP004727629, ISSN: 0165-6147 *

Also Published As

Publication number Publication date
WO2007003768A2 (en) 2007-01-11
FR2887773B1 (en) 2008-05-30
FR2887773A1 (en) 2007-01-05

Similar Documents

Publication Publication Date Title
GB2431876B (en) Use of para-coumaric acid or para-hydroxycinnamic acid derivatives in cosmetic or dermatological compositions
WO2006136607A3 (en) Use of hydrophobin-polypeptides and conjugates from hydrophobin-polypeptides having active and effect agents and the production thereof and use thereof in the cosmetic industry
GB2396297B (en) A cosmetic or dermopharmaceutical composition comprising an enzyme which is insoluble in an aqueous medium, as well as its uses.
WO2007038459A3 (en) Carboxyamine compounds and their use in the treatment of hdac dependent diseases
WO2010065709A3 (en) Hydroxamic acid derivatives, preparation and therapeutic uses thereof
WO2006094093A3 (en) A method for identifying skin care composition-resistant skin-binding peptides
WO2009074735A8 (en) Use of a novel natural agent in cosmetic compositions
WO2007149406A3 (en) Modified coagulation factor ix polypeptides and use thereof for treatment
WO2007141392A3 (en) Compositions comprising betulonic acid
WO2009017369A3 (en) Compositions for skin protection and improvement of skin diseases containing the dibenzo-p-dioxine derivatives
MX2010004687A (en) Keratin derivatives and methods of making the same.
WO2008015343A3 (en) Use of a yeast extract as active agent for increasing melanin synthesis in melanocytes
WO2010031657A3 (en) Use of urea derivatives and phenacylthiazolium salts for the treatment of body odour
WO2006042661A3 (en) Oligopeptides and their use in cosmetics
WO2006089114A3 (en) Methods and compositions for treating an anthrax toxin mediated condition
TW200718430A (en) Cosmetic powder
WO2006117465A3 (en) Use ot cacao polyphenols for controlling skin pigmentation
WO2009044279A3 (en) Peptides having antimicrobial and/or biosurfactant properties
MX2007003465A (en) Cosmetic composition comprising at least one hydroxy acid, at least one mono- or disaccharide and at least one ceramide, and process for the preparation thereof.
IL186050A0 (en) Novel isoindole derivatives, compositions containing same, preparation thereof and pharmaceutical uses thereof in particular as inhibitors of chaperone protein hsp90 activities
WO2007077318A3 (en) Use of a peptidic rice extract as an active agent inducing the synthesis of sirt proteins in skin cells
PT2459153E (en) Pharmaceutical or cosmetic or dietetic composition for promoting a hair pigmentation effect
CA2494473A1 (en) Stabilized protein compositions for topical administration and methods of making same
WO2006018454A3 (en) Cosmetic preparation comprising hyaluronic acid and saponins for treatment of skin aging phenomena
WO2008015342A3 (en) Use of a plant extract as active agent for increasing melanin synthesis in melanocytes

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06778714

Country of ref document: EP

Kind code of ref document: A2